tiprankstipranks
SAB Biotherapeutics initiated with an Outperform at Oppenheimer
PremiumThe FlySAB Biotherapeutics initiated with an Outperform at Oppenheimer
4M ago
SAB Biotherapeutics founds Clinical Advisory Board for SAB-142 development
Premium
The Fly
SAB Biotherapeutics founds Clinical Advisory Board for SAB-142 development
5M ago
SAB Biotherapeutics Announces Key Executive Appointment
Premium
Company Announcements
SAB Biotherapeutics Announces Key Executive Appointment
5M ago
SAB Biotherapeutics initiated with a Buy at Brookline
PremiumThe FlySAB Biotherapeutics initiated with a Buy at Brookline
7M ago
SAB Biotherapeutics Appoints Mr. Conley, Details Public Disclosure
Premium
Company Announcements
SAB Biotherapeutics Appoints Mr. Conley, Details Public Disclosure
7M ago
SAB Biotherapeutics announces FDA clearance for SAB-142 IND application
Premium
The Fly
SAB Biotherapeutics announces FDA clearance for SAB-142 IND application
7M ago
SAB Biotherapeutics price target lowered to $6 from $10 at H.C. Wainwright
PremiumThe FlySAB Biotherapeutics price target lowered to $6 from $10 at H.C. Wainwright
9M ago
SABS Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
SABS Earnings this Week: How Will it Perform?
9M ago
SAB Biotherapeutics enters partnership with Naval Medical Research Center
Premium
The Fly
SAB Biotherapeutics enters partnership with Naval Medical Research Center
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100